Rocky, thanks for the clarification.
I wasn't trying to pump or be outrageous in the post, but repeating the essence of what I thought I quickly read somewhere, perhaps iCell?
I realize we are still a way from proving the science and from commercialism, especially still being at stages I and II, with many approvals and hurdles still ahead.
At anyrate, is it reasonable/responsible to say the implication is, if once commercial, it has the blockbuster revenue potential of a Lipitor?
Market Data 
Markets 
AI
